feed,title,long_url,short_url
Barron's,"Buy Bristol Myers, Analyst Says. It Isn't Getting Enough Credit for Its Drug Pipeline.",https://www.barrons.com/articles/bristol-myers-squibb-stock-upgrade-drug-pipeline-51618322063?mod=RTA,https://j.mp/3e54K3E
